ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PRPO Precipio Inc

5.7499
-0.1501 (-2.54%)
After Hours
Last Updated: 15:00:06
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Precipio Inc PRPO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.1501 -2.54% 5.7499 15:00:06
Open Price Low Price High Price Close Price Previous Close
5.91 5.61 6.079 5.7499 5.90
more quote information »

Recent News

Date Time Source Heading
3/25/202416:00GLOBEPrecipio Announces Year end 2023 Shareholder Update Call
2/13/202409:00GLOBEPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues,..
2/06/202409:00GLOBEPrecipio and Cardinal Health Sign Distribution Agreement for..
1/23/202409:00GLOBEPrecipio’s Q4-2023 Cash Burn From Operations (unaudited)..
1/19/202415:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/17/202409:30GLOBEPrecipio Signs Distribution Agreement For IV-Cell® and..
1/04/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202415:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/02/202416:01EDGAR2Form 8-K - Current report
1/02/202408:00GLOBEPrecipio Announces Christina Valauri joins the Board of..
12/14/202316:00EDGAR2Form 8-K - Current report
12/14/202315:30GLOBEPrecipio Management Shares Thoughts on 2023, and Looks Ahead..
11/16/202316:15EDGAR2Form 8-K - Current report
11/16/202316:00GLOBEPrecipio Announces Q3-2023 Shareholder Update Call
11/13/202315:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/31/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/26/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/18/202308:00GLOBEPrecipio to Report $4.5M Q3-2023 Revenues, Double From..
10/06/202315:34EDGAR2Form 8-K - Current report
10/03/202309:00GLOBEPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines..
9/28/202308:00GLOBEPrecipio Continues to Sign New HemeScreen™ Customers
9/25/202310:00GLOBEPrecipio Reduces Product Revenue Result Needed for Cash Flow..
9/21/202316:10EDGAR2Form 8-K - Current report
9/14/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/13/202308:30GLOBEPrecipio’s Pathology Division Exceeds Breakeven Revenues in..
8/14/202315:00EDGAR2Form 8-K - Current report
8/11/202315:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:00GLOBEPrecipio Announces Q2-2023 Shareholder Update Call
8/08/202308:00GLOBEPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL..
8/03/202308:00GLOBEPrecipio’s Operational Efficiency Measures Continue To..
8/01/202308:00GLOBEPrecipio Unaudited Q2-2023 Revenues Show combined increase..
7/07/202315:30EDGAR2Form S-1 - General form for registration of securities under..
6/14/202308:49GLOBEPrecipio’s Omnia™ Methodology Enables Diagnosis of MDS With..
6/13/202308:00GLOBEPrecipio Enters into Collaboration with Prestigious New..
6/08/202307:30GLOBEPrecipio, Inc. Announces Pricing of $2 Million Registered..
6/07/202308:30GLOBEProjected cash burn reduced by $1.5 million annually from..
5/22/202310:00GLOBEPrecipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of..
5/17/202315:00GLOBEPrecipio Shares Growth Catalysts For HemeScreen
5/15/202315:00GLOBEPrecipio Announces Q1-2023 Shareholder Update Call
5/04/202312:00GLOBEPrecipio Adds Substantial Pathology Customer to its..
5/04/202309:00GLOBEPrecipio Signs Another HemeScreen™ Customer

Your Recent History

Delayed Upgrade Clock